永安行：8月27日召开董事会会议

Group 1 - The company, Yong'anxing, announced on August 28 that its fifth board meeting was held on August 27, 2025, combining in-person and remote voting methods [1] - The meeting reviewed the proposal regarding the company's 2025 semi-annual report in full and summary [1] Group 2 - The news highlights a significant medical advancement with the world's first successful transplantation of gene-edited pig lungs into humans, raising questions about the timeline for clinical applications [1]